KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Assets (2016 - 2025)

TherapeuticsMD's Return on Assets history spans 14 years, with the latest figure at 0.0% for Q4 2025.

  • For Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Assets reached 0.0% in Q4 2025 per TXMD's latest filing, down from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 1.88% in Q1 2023 to a low of 0.82% in Q3 2021.
  • Average Return on Assets over 5 years is 0.1%, with a median of 0.0% recorded in 2025.
  • Peak YoY movement for Return on Assets: soared 235bps in 2023, then plummeted -190bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.42% in 2021, then skyrocketed by 336bps to 0.99% in 2022, then crashed by -106bps to 0.05% in 2023, then surged by 106bps to 0.0% in 2024, then tumbled by -34bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Return on Assets are 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.0% (Q2 2025).